The aim of this study is to investigate options for protecting workers from exposure to hazardous medicinal products (HMPs), including cytotoxic medicinal products, that fall within the scope of the CMD (the Carcinogens and Mutagens Directive (2004/37 EC)).

Disponibilă pe